Pharmacokinetics of Intraperitoneal Cefotaxime in Children with Peritonitis Undergoing Continuous Ambulatory Peritoneal Dialysis

Abstract

View all access options for this article.

Dell

, Chamberlain

, Coppin

Determination ofcefotaxime and desacetyl-cefotaxime in plasma and urine by high-performance liquid chromatography.

J Chromatogr. 1981; 226: 431–440.

Albin

H.C.

, Demotes-Mainard

F.M.

, Bouchet

J.L.

Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.

Clin Pharmacol Ther. 1985; 38: 285–289.

Hasegawa

, Imada

, Horiuchi

Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.

J. Antimicrobial Chemother. 1984; 14(Suppl B): 135–142.

Alexander

, Gambertoglio

, Barriere

Cefotaxime (C) pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).

Clin Pharmacal Ther. 1984; 35: 225.

Heim

K.L.

, Halstenson

C.E.

, Compty

C.M.

Pharma-cokinetics of cefotaxime during CAPD. In: Maher

J.F.

, Winchester

J.F.

, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Ass.; 1986: 125–130.

Petersen

, Stewart

R.D.M.

, Cat to

G.R.D.

Pharmaco-kinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.

Nephron. 1985; 40: 79–82.